HIV-1 specific chimeric antigen receptor cell therapy (Guangzhou 8th People's Hospital)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameHIV-1 specific chimeric antigen receptor cell therapy (Guangzhou 8th People's Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangzhou 8th People'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou 8th People'S Hospital
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A